Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04262687
Title Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate (POCHI)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Federation Francophone de Cancerologie Digestive

colorectal adenocarcinoma


Bevacizumab + Capecitabine + Oxaliplatin + Pembrolizumab

Age Groups: adult | senior
Covered Countries FRA

Additional content available in CKB BOOST